NOVERA RETATRUTIDE: THE NEW APPROACH FOR WEIGHT CONTROL?

Emerging clinical information suggests that Novera Retatrutide, a combined-action therapy from Novo Nordisk, could represent a meaningful breakthrough in weight control. Unlike many existing drugs, Retatrutide impacts both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polyp